Publications by authors named "Monica Capozzi"

Claim this Profile
C
CAR-T cell therapy for breast cancer: Current status and future perspective.
Giuseppe Buono, Monica Capozzi, Roberta Caputo, Vincenzo Di Lauro, Daniela Cianniello

Cancer Treat Rev· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives.
Alessandro Ottaiano, Massimiliano Berretta, Claudia Von Arx, Monica Capozzi, Michele Caraglia

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
Alessandro Ottaiano, Stefania Scala, Nicola Normanno, Gerardo Botti, Fabiana Tatangelo, Monica Capozzi

Appl Immunohistochem Mol Morphol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Autophagy in Breast Cancer.
Stefania Cocco, Alessandra Leone, Michela Piezzo, Roberta Caputo, Vincenzo Di Lauro, Monica Capozzi

Int J Mol Sci· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potential prognostic marker in primitive lung neuroendocrine tumor: A case report.
Luigi Russo, Bruna Grilli, Anita Minopoli, Monica Capozzi, Salvatore Tafuto

Int J Biol Markers· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer.
Alessandro Ottaiano, Luisa Circelli, Angela Lombardi, Stefania Scala, Nicola Martucci, Monica Capozzi

Cell Death Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.
Alessandro Ottaiano, Stefania Scala, Nicola Normanno, Maria Napolitano, Monica Capozzi

BMC Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms.
Salvatore Tafuto, Claudia von Arx, Monica Capozzi, Fabiana Tatangelo, Manuela Mura

J Clin Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms.
Claudia von Arx, Monica Capozzi, Elena López-Jiménez, Alessandro Ottaiano, Fabiana Tatangelo

J Clin Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice.
Alessandro Ottaiano, Monica Capozzi, Salvatore Tafuto, Alfonso De Stefano, Chiara De Divitiis

Front Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment.
Monica Capozzi, Chiara De Divitiis, Alessandro Ottaiano, Claudia von Arx, Stefania Scala

Cancer Manag Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity and Cancer: Biological Links and Treatment Implications.
Alessandro Ottaiano, Chiara De Divitiis, Monica Capozzi, Antonio Avallone, Carmen Pisano

Curr Cancer Drug Targets· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Funds Reimbursement of High-Cost Drugs in Gastrointestinal Oncology: An Italian Real Practice 1 Year Experience at the National Cancer Institute of Naples.
Monica Capozzi, Chiara De Divitiis, Alessandro Ottaiano, Tramontano Teresa, Maurizio Capuozzo

Front Public Health· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors.
Alessandro Ottaiano, Valerio Scotti, Chiara De Divitiis, Monica Capozzi, Carmen Romano

Oncotarget· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis.
Alessandro Ottaiano, Alfonso De Stefano, Monica Capozzi, Anna Nappi, Chiara De Divitiis

Front Pharmacol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?
Alessandro Ottaiano, Antonino Cassata, Monica Capozzi, Chiara De Divitiis, Alfonso De Stefano

Front Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cells activity in a metastatic colorectal cancer patient with complete and long lasting response to therapy.
Alessandro Ottaiano, Maria Napolitano, Monica Capozzi, Salvatore Tafuto, Antonio Avallone

World J Clin Cases· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples.
Alessandro Ottaiano, Monica Capozzi, Chiara DE Divitiis, Claudia VON Arx, Elena DI Girolamo

Anticancer Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials.
Alessandro Ottaiano, Monica Capozzi, Chiara De Divitiis, Alfonso De Stefano, Gerardo Botti

Acta Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiangiogenic Therapy in Pancreatic Neuroendocrine Tumors.
Monica Capozzi, Claudia VON Arx, Chiara DE Divitiis, Alessandro Ottaiano, Fabiana Tatangelo

Anticancer Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy.
Alessandro Ottaiano, Anna Nappi, Salvatore Tafuto, Guglielmo Nasti, Chiara De Divitiis, Monica Capozzi

Oncology· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus and pancreatic neuroendocrine tumors (PNETs): Activity, resistance and how to overcome it.
Monica Capozzi, Ieranò Caterina, Chiara De Divitiis, Claudia von Arx, Piera Maiolino

Int J Surg· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis